Clinical Trial

9MW2821 Combined With Other Antitumor Drugs in Patients With Advanced Gynecological Tumors

Name: 9MW2821 Combined With Other Antitumor Drugs in Patients With Advanced Gynecological Tumors — clinical trial record (NCT06926998)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

To evaluate the safety, tolerability, and preliminary efficacy of 9MW2821 in combination with other anti-tumor agents in patients with advanced gynecological malignancies.

Trial Details

NCT Number	NCT06926998
Lead Sponsor	Mabwell (Shanghai) Bioscience Co., Ltd.
Conditions	Gynecological Malignancies
Enrollment	260 participants
Start Date	2025-04-15
Primary Completion	2027-05-01 (estimated)
Study Completion	2027-05-01 (estimated)
Updated on ClinicalTrials.gov	2025-04-15